The ICU LIBERATION Study
Launched by JAPANESE SOCIETY FOR EARLY MOBILIZATION · Apr 25, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
The ICU LIBERATION Study is researching how to improve care for patients with Acute Respiratory Distress Syndrome (ARDS), a serious condition that affects breathing and often requires the use of ventilators in the Intensive Care Unit (ICU). The study aims to understand the types of treatments patients receive, how well these treatments are implemented, and how these factors affect patient outcomes and quality of life after their ICU stay. By collecting daily information on patients' breathing conditions and the care they receive, the researchers hope to create better guidelines for ICU care that can lead to improved recovery for ARDS patients.
To participate in this study, you need to be 16 years or older, have been placed on a ventilator within 24 hours of being admitted to the ICU, and be expected to need ventilation for more than 48 hours. Unfortunately, patients with terminal conditions or those who do not wish to have their data used for research are not eligible. If you join the study, you can expect close monitoring and support as part of the effort to enhance the overall quality of ICU care for patients like you, especially in light of the challenges posed by the recent pandemic.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients on an invasive or non-invasive ventilator within 24 hours of ICU admission
- • 2. Patients who are expected to be on an invasive and/or non-invasive ventilator for more than 48 hours in total
- • 3. Patients who meet the diagnosis of ARDS within 24 hours of ICU admission
- Exclusion Criteria:
- • 1. Patients who are younger than 16 years old
- • 2. Patients with terminal conditions at the time of ICU admission
- • 3. Patients who have been admitted to the ICU with a terminal care policy or who are expected to be admitted to the ICU with a terminal care policy within 24 hours of admission to the ICU
- • 4. Patients who have expressed their refusal to have their clinical data used in research.
About Japanese Society For Early Mobilization
The Japanese Society for Early Mobilization is a prominent clinical trial sponsor dedicated to advancing research and practices that promote early mobilization in patient care. Committed to enhancing recovery outcomes and minimizing complications in various clinical settings, the Society focuses on developing evidence-based guidelines and fostering collaboration among healthcare professionals. Through its rigorous research initiatives, the Society aims to establish best practices that improve patient mobility, ultimately contributing to higher standards of care and better quality of life for individuals across Japan and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tokyo, , Japan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported